International Patent: RECOMBINANT INFLUENZA VIRUS PROTEIN, VACCINE, AND PREPARATION METHOD THEREFOR AND USE THEREOF

GENEVA, July 2 -- WESTVAC BIOPHARMA CO., LTD. filed a patent application (CN2025/099265) for “RECOMBINANT INFLUENZA VIRUS PROTEIN, VACCINE, AND PREPARATION METHOD THEREFOR AND USE THEREOF”. With publication no. WO/2026/129566, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 14/11

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....